↓ Skip to main content

Cochrane Database of Systematic Reviews

Pharmacological treatment of depression in patients with a primary brain tumour

Overview of attention for article published in Cochrane database of systematic reviews, May 2013
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
104 Mendeley
Title
Pharmacological treatment of depression in patients with a primary brain tumour
Published in
Cochrane database of systematic reviews, May 2013
DOI 10.1002/14651858.cd006932.pub3
Pubmed ID
Authors

Alasdair G Rooney, Robin Grant

Abstract

This is an updated version of the original Cochrane review published in Issue 3, 2010.Patients with a primary brain tumour often experience depression, for which drug treatment may be prescribed. However, these patients are also at high risk of epileptic seizures, cognitive impairment and fatigue, all of which are potential side effects of antidepressants. The benefit, or harm, of pharmacological treatment of depression in brain tumour patients is unclear.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
Norway 1 <1%
Unknown 102 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 17 16%
Student > Bachelor 17 16%
Student > Doctoral Student 13 13%
Researcher 10 10%
Student > Ph. D. Student 7 7%
Other 20 19%
Unknown 20 19%
Readers by discipline Count As %
Medicine and Dentistry 30 29%
Psychology 15 14%
Nursing and Health Professions 13 13%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Social Sciences 4 4%
Other 9 9%
Unknown 29 28%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 May 2013.
All research outputs
#12,532,460
of 15,776,260 outputs
Outputs from Cochrane database of systematic reviews
#10,349
of 11,280 outputs
Outputs of similar age
#112,932
of 158,051 outputs
Outputs of similar age from Cochrane database of systematic reviews
#107
of 124 outputs
Altmetric has tracked 15,776,260 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,280 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.5. This one is in the 2nd percentile – i.e., 2% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 158,051 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 124 others from the same source and published within six weeks on either side of this one. This one is in the 4th percentile – i.e., 4% of its contemporaries scored the same or lower than it.